Rothamsted Research Plants Autumn-sown Wheat as Part of its GM Field Trial
News Jun 18, 2013
Rothamsted Research has been granted permission by Defra to extend its current GM wheat field trial to include additional autumn-sown cadenza wheat. This will give additional data under a more diverse range of environmental conditions.
Rothamsted submitted a request to Defra on March 25th, which was assessed by the independent Advisory Committee on Releases to the Environment (ACRE), and by members of the public through a 60-day consultation period. ACRE is satisfied that all scientific issues raised by the public with respect to this application have been addressed.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.